Integrated Intervention for Breast Cancer Survivors With Diabetes

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

July 24, 2023

Study Completion Date

July 24, 2023

Conditions
DiabetesBreast Cancer
Interventions
BEHAVIORAL

Integrated Intervention for Breast Cancer Survivors with Diabetes

"All pilot participants will be required to have a SMB target to be included in this study. A SMB target will be chosen by the participant after reviewing their 18mo follow-up responses with the Care Coach. Participants may endorse a maladaptive belief or emotional response; however, this is not required to participate in this intervention. At each follow-up session, the Care Coach will review the participant's SMB goal and progress, address participant's challenges and suggest alternatives, and correct further misinformation on the disease(s). Additionally, the Care Coach will reinforce or introduce techniques that could help overcome barriers to reaching SMB goal and recommend participants to continue improving on the same goal or begin action planning towards a new SMB goal.~1. Just SMB concern~2. SMB + maladaptive belief + emotional response~3. SMB + maladaptive belief~4. SMB + emotional response"

BEHAVIORAL

Attention Control

Participants in the control arm will receive a brochure to discuss healthy lifestyle behaviors to improve DM management. To control for the potentially confounding effect of personalized attention from the care coach on the relationship between the intervention and outcomes, participants also receive 4 calls to discuss study progress, thoughts and feelings about study/illness/behaviors, remind them about returning their pill bottles, and about scheduling for their upcoming 24mo follow-up study interview.

Trial Locations (3)

10029

Icahn School of Medicine at Mount Sinai, New York

11040

Northwell Health, New Hyde Park

60611

Feinberg School of Medicine, Chicago

All Listed Sponsors
collaborator

Northwestern University Feinberg School of Medicine

OTHER

collaborator

Feinstein Institute for Medical Research

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER